VIEWS

Oaktree Capital chief calls AI advancement “unlike anything we’ve seen before,” flags job displacement fears while urging moderate, selective investing approach Howard Marks, co-founder and co-chairman of Oaktree Capital Management, has released his latest client memo titled “AI Hurtles Ahead,” a follow-up to his December 2025 piece “Is It aContinue Reading

STOCKS

Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls  IPCA Laboratories has emerged as a growth story in India’s pharmaceutical sector with two leading brokerages issuing buy recommendations following the company’s third-quarter performance that showcased margin expansion even as revenue growth remained modest. TheContinue Reading